The role of hormone replacement therapy in the intensive care management of deceased organ donors: a primer for nurses

Critical Care Nursing Quarterly
Keaton S SmetanaG Morgan Jones

Abstract

Donation after brain death remains the primary contributor to the supply of organs available for transplantation in the United States. After brain death, both a surge of catecholamines and a dysregulation of the neurohormonal axis may result in hypotension, decreased organ perfusion, and reduced viability of organs to be transplanted. Hormone replacement therapy is widely used to maintain organ perfusion and has been shown to increase the number of organs procured. This article reviews the literature and mechanisms supporting the use of hormone replacement therapy in brain-dead organ donors and provides clinicians with information regarding the administration, monitoring, and preparation of thyroid hormone, arginine vasopressin, and corticosteroids.

References

Nov 1, 1992·Transplantation·H J GrammK Voigt
Jan 1, 1991·Annales Françaises D'anesthèsie Et De Rèanimation·J MariotP Strub
Jul 1, 1991·The Journal of Clinical Endocrinology and Metabolism·G MintzI Klein
Aug 1, 1985·Annals of Internal Medicine·D W Richardson, A G Robinson
Jun 1, 1995·Metabolism: Clinical and Experimental·J A AmadoM T García-Unzueta
Jan 15, 1995·Transplantation·S H PennefatherJ H Dark
Feb 1, 1996·The Annals of Thoracic Surgery·S WanJ L LeClerc
Feb 1, 1997·Thyroid : Official Journal of the American Thyroid Association·V Jeevanandam
Sep 23, 1997·The American Journal of the Medical Sciences·A B Van Bakel
Jul 18, 2000·The Surgical Clinics of North America·T RazekP M Reilly
Feb 24, 2001·American Journal of Respiratory and Critical Care Medicine·A J FisherP A Corris
Dec 26, 2001·Archives of Surgery·A SalimD Demetriades
Sep 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·John D RosendaleH Myron Kauffman
Feb 28, 2003·Transplantation·John D RosendaleBruce R Rosengard
Jun 28, 2003·Transplantation·Vassilios S AvlonitisJohn H Dark
Dec 24, 2004·The New England Journal of Medicine·Kenneth E WoodDouglas B Coursin
Jun 7, 2005·Intensive Care Medicine·Alicia Pérez-BlancoJosé Sanchez-Payá
Mar 15, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sam D ShemieUNKNOWN Pediatric Recommendations Group
Jan 20, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Kelly M McLeanJeffrey M Pearl
Aug 18, 2009·Acta Anaesthesiologica Scandinavica·J F Bugge
Dec 16, 2009·Clinical Transplantation·C DictusR Ahmadi
Jun 20, 2012·The Journal of Trauma and Acute Care Surgery·David S PluradBrant Putnam
Apr 3, 2013·Transplantation·Tatiana H RechCristiane B Leitão
Jun 4, 2014·Endocrinology and Metabolism Clinics of North America·Sara Danzi, Irwin Klein
Jul 25, 2014·Critical Care : the Official Journal of the Critical Care Forum·Michel PinsardNicolas Pichon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.